Title | Description |
|---|---|
| Trial ID | GRT-PK-07 |
| Compound | Cebranopadol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 1 |
| Brief title | A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol |
| Indication | Pharmacokinetic |
| UTN | |
| CTG ID | NCT03882762 |
| CTIS ID (former EudraCT) | |
| Trial status | Completed |
| FPI | June 20, 2013 |
| LPO | September 17, 2014 |
| Countries | United States |
| Gender | All |
| Age | 18 Years to 75 Years |
| Results | No |
| Pubmed | |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.